Most cited papers in Antifungal resistance and susceptibility
What are the most cited papers in Antifungal resistance and susceptibility?
The most cited paper in Antifungal resistance and susceptibility is "Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group" (Ben de Pauw et al., 2008), with 4,957 citations. Next come "Hidden Killers: Human Fungal Infections" (4,407) and "Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem" (4,219).
Showing 50 of 99 papers. Every paper with more than 967 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Ben de Pauw et al. · Clinical Infectious Diseases | 7 May 2008 | 4,957 |
| 2 | Hidden Killers: Human Fungal Infections Gordon D. Brown, David W. Denning, Neil A. R. Gow et al. · Science Translational Medicine | 19 Dec 2012 | 4,407 |
| 3 | Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem Michael A. Pfaller, Daniel J. Diekema · Clinical Microbiology Reviews | 2007 | 4,219 |
| 4 | Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes et al. · Clinical Infectious Diseases | 16 Dec 2015 | 4,217 |
| 5 | J Antimicrob Chemother 1994; 33: 350–351 Elizabeth M. O’Shaughnessy, SATYA S. DAS · Journal of Antimicrobial Chemotherapy | 1994 | 3,753 |
| 6 | Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Alison G. Freifeld, Eric J. Bow, Kent A. Sepkowitz et al. · Clinical Infectious Diseases | 22 Jan 2011 | 3,477 |
| 7 | Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis Raoul Herbrecht et al. · New England Journal of Medicine | 8 Aug 2002 | 3,326 |
| 8 | Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes et al. · Clinical Infectious Diseases | 29 Jan 2009 | 3,216 |
| 9 | Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases Maureen M. Roden, Theoklis E. Zaoutis, Wendy L. Buchanan et al. · Clinical Infectious Diseases | 5 Aug 2005 | 3,065 |
| 10 | Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision Felix Bongomin, Sara Gago, Rita Okeoghene Oladele et al. · Journal of Fungi | 18 Oct 2017 | 3,017 |
| 11 | Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium J. Peter Donnelly et al. · Clinical Infectious Diseases | 8 Oct 2019 | 2,973 |
| 12 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America Thomas F. Patterson, George R. Thompson, David W. Denning et al. · Clinical Infectious Diseases | 29 Jun 2016 | 2,932 |
| 13 | Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America Thomas J. Walsh, Elias J. Anaissie, David W. Denning et al. · Clinical Infectious Diseases | 4 Jan 2008 | 2,721 |
| 14 | Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America John R. Perfect, William E. Dismukes, Françoise Dromer et al. · Clinical Infectious Diseases | 4 Jan 2010 | 2,710 |
| 15 | Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus S. Ascioglu, John H. Rex, Ben de Pauw et al. · Clinical Infectious Diseases | 2002 | 2,349 |
| 16 | Aspergillus fumigatus and Aspergillosis Jean‐Paul Latgé · Clinical Microbiology Reviews | Apr 1999 | 2,311 |
| 17 | Implant infections: adhesion, biofilm formation and immune evasion Carla Renata Arciola, Davide Campoccia, Lucio Montanaro · Nature Reviews Microbiology | 2 May 2018 | 2,274 |
| 18 | Candida albicans pathogenicity mechanisms François L. Mayer, Duncan Wilson, Bernhard Hube · Virulence | 7 Feb 2013 | 1,868 |
| 19 | Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Oliver A. Cornely et al. · The Lancet Infectious Diseases | 4 Nov 2019 | 1,841 |
| 20 | Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells Eva V. Acosta Rodríguez, Laura Rivino, Jens Geginat et al. · Nature Immunology | 7 May 2007 | 1,840 |
| 21 | Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia Oliver A. Cornely, Johan A. Maertens, Drew J. Winston et al. · New England Journal of Medicine | 25 Jan 2007 | 1,824 |
| 22 | Nonfilamentous C. albicans Mutants Are Avirulent Hsiu‐Jung Lo, Julia R. Köhler, Beth DiDomenico et al. · Cell | Sep 1997 | 1,821 |
| 23 | Immunity to fungal infections Luigina R. Romani · Nature reviews. Immunology | 11 Mar 2011 | 1,816 |
| 24 | Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance Mahmoud Afif Ghannoum, Louis B. Rice · Clinical Microbiology Reviews | Oct 1999 | 1,807 |
| 25 | Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses Shawn R. Lockhart, Kizee A. Etienne, Snigdha Vallabhaneni et al. · Clinical Infectious Diseases | 14 Oct 2016 | 1,713 |
| 26 | Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing Timothy M. Rawson, Luke S. P. Moore, Nina Zhu et al. · Clinical Infectious Diseases | 30 Apr 2020 | 1,711 |
| 27 | Isogenic strain construction and gene mapping in Candida albicans. William A. Fonzi, M Y Irwin · Genetics | Jul 1993 | 1,707 |
| 28 | Co-infections in people with COVID-19: a systematic review and meta-analysis Louise Lansbury, Benjamin Syek Hur Lim, Vadsala Baskaran et al. · Journal of Infection | 27 May 2020 | 1,693 |
| 29 | Biofilm Formation by the Fungal Pathogen Candida albicans : Development, Architecture, and Drug Resistance Jyotsna Chandra, Duncan M. Kuhn, Pranab K. Mukherjee et al. · Journal of Bacteriology | 15 Sep 2001 | 1,594 |
| 30 | Worldwide emergence of resistance to antifungal drugs challenges human health and food security Matthew C. Fisher, Nichola J. Hawkins, Dominique Sanglard et al. · Science | 17 May 2018 | 1,588 |
| 31 | Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline Andrew J. Ullmann et al. · Clinical Microbiology and Infection | 18 Mar 2018 | 1,576 |
| 32 | Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Peter G. Pappas et al. · Clinical Infectious Diseases | 10 Mar 2010 | 1,574 |
| 33 | Global incidence and mortality of severe fungal disease David W. Denning · The Lancet Infectious Diseases | 21 Jan 2024 | 1,551 |
| 34 | Invasive candidiasis Peter G. Pappas, Michail S. Lionakis, Maiken Cavling Arendrup et al. · Nature Reviews Disease Primers | 10 May 2018 | 1,545 |
| 35 | Novel Perspectives on Mucormycosis: Pathophysiology, Presentation, and Management Brad J. Spellberg, John Ernest Edwards, Ashraf S. Ibrahim · Clinical Microbiology Reviews | Jul 2005 | 1,541 |
| 36 | Invasive Aspergillosis David W. Denning · Clinical Infectious Diseases | Apr 1998 | 1,497 |
| 37 | Epidemiology and Clinical Manifestations of Mucormycosis George L. Petrikkos, Anna Skiada, Olivier Lortholary et al. · Clinical Infectious Diseases | 13 Jan 2012 | 1,468 |
| 38 | Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database Dimitrios P. Kontoyiannis et al. · Clinical Infectious Diseases | 10 Mar 2010 | 1,466 |
| 39 | Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients Kieren A. Marr, Rachel A. Carter, Fulvio Crippa et al. · Clinical Infectious Diseases | Apr 2002 | 1,461 |
| 40 | Guidelines for Treatment of Candidiasis Peter G. Pappas, John H. Rex, Jack D. Sobel et al. · Clinical Infectious Diseases | 6 Jan 2004 | 1,453 |
| 41 | Aspergillosis Case-Fatality Rate: Systematic Review of the Literature Swu‐Jane Lin, Jennifer Schranz, Steven M. Teutsch · Clinical Infectious Diseases | Feb 2001 | 1,427 |
| 42 | Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus William C. Nierman et al. · Nature | 21 Dec 2005 | 1,417 |
| 43 | Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis Jorge Mora-Duarte, Robert F. Betts, Coleman Rotstein et al. · New England Journal of Medicine | 18 Dec 2002 | 1,391 |
| 44 | Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America Lawrence Joseph Wheat, Alison G. Freifeld, Martin B. Kleiman et al. · Clinical Infectious Diseases | 4 Sep 2007 | 1,385 |
| 45 | Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance Theodore C. White, Kieren A. Marr, Raleigh Anne Bowden · Clinical Microbiology Reviews | Apr 1998 | 1,361 |
| 46 | Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease Andrew J. Ullmann, Jeffrey Howard Lipton, David H. Vesole et al. · New England Journal of Medicine | 25 Jan 2007 | 1,347 |
| 47 | Virulence factors of Candida albicans Richard Calderone, William A. Fonzi · Trends in Microbiology | Jul 2001 | 1,346 |
| 48 | The structure and synthesis of the fungal cell wall Shaun M. Bowman, Stephen J. Free · BioEssays | Aug 2006 | 1,332 |
| 49 | Zygomycetes in Human Disease Julie A. Ribes, Carolyn L. Vanover-Sams, Donald J. Baker · Clinical Microbiology Reviews | Apr 2000 | 1,320 |
| 50 | Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America Peter G. Pappas, Carol A. Kauffman, David R. Andes et al. · Clinical Infectious Diseases | 22 Jan 2016 | 1,302 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.